243 related articles for article (PubMed ID: 12942702)
1. The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren's syndrome.
Haghighat N; al-Hashimi I
Clin Exp Rheumatol; 2003; 21(4):485-8. PubMed ID: 12942702
[TBL] [Abstract][Full Text] [Related]
2. Lectin binding studies of parotid salivary glycoproteins in Sjögren's syndrome.
Carpenter GH; Pankhurst CL; Proctor GB
Electrophoresis; 1999 Jul; 20(10):2124-32. PubMed ID: 10451125
[TBL] [Abstract][Full Text] [Related]
3. Salivary lactoferrin in primary Sjögren's syndrome.
Jezequel N; Depasse F; Jouquan J; Lelong A; Roncin S; Pare G; Pennec YL; Youinou P
Clin Exp Rheumatol; 1989; 7(2):123-5. PubMed ID: 2736823
[TBL] [Abstract][Full Text] [Related]
4. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis.
Ryu OH; Atkinson JC; Hoehn GT; Illei GG; Hart TC
Rheumatology (Oxford); 2006 Sep; 45(9):1077-86. PubMed ID: 16522680
[TBL] [Abstract][Full Text] [Related]
5. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
6. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
7. Saliva: an additional diagnostic tool in Sjögren's syndrome.
Tishler M; Yaron I; Shirazi I; Yaron M
Semin Arthritis Rheum; 1997 Dec; 27(3):173-9. PubMed ID: 9431589
[TBL] [Abstract][Full Text] [Related]
8. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of salivary fluid levels of beta 2-microglobulin, lysozyme and lactoferrin for primary Sjögren's syndrome.
Markusse HM; Otten HG; Vroom TM; Smeets TJ; Fokkens N; Breedveld FC
Clin Rheumatol; 1992 Dec; 11(4):521-5. PubMed ID: 1486744
[TBL] [Abstract][Full Text] [Related]
10. Salivary S100A8/A9 in Sjögren's syndrome accompanied by lymphoma.
Jazzar AA; Shirlaw PJ; Carpenter GH; Challacombe SJ; Proctor GB
J Oral Pathol Med; 2018 Oct; 47(9):900-906. PubMed ID: 29998578
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis.
Fine DH; Furgang D; Beydouin F
J Periodontol; 2002 Jun; 73(6):624-30. PubMed ID: 12083535
[TBL] [Abstract][Full Text] [Related]
12. Sialochemical markers of salivary gland involvement with Sjögren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis.
Carpenter GH; Proctor GB; Pankhurst CL; O'Donohue J; Scott D; Hunnable MP
J Oral Pathol Med; 2000 Oct; 29(9):452-9. PubMed ID: 11016688
[TBL] [Abstract][Full Text] [Related]
13. [Salivary epidermal growth factor (EGF) in Sjögren's syndrome: association between salivary EGF levels and the severity of intraoral manifestations].
Azuma N; Katada Y; Kitano S; Nishioka A; Sekiguchi M; Kitano M; Hashimoto N; Matsui K; Iwasaki T; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):42-50. PubMed ID: 27181234
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome.
Ryo K; Yamada H; Nakagawa Y; Tai Y; Obara K; Inoue H; Mishima K; Saito I
Pathobiology; 2006; 73(5):252-60. PubMed ID: 17314496
[TBL] [Abstract][Full Text] [Related]
16. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
[TBL] [Abstract][Full Text] [Related]
17. Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome.
Kalk WW; Vissink A; Stegenga B; Bootsma H; Nieuw Amerongen AV; Kallenberg CG
Ann Rheum Dis; 2002 Feb; 61(2):137-44. PubMed ID: 11796400
[TBL] [Abstract][Full Text] [Related]
18. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
[TBL] [Abstract][Full Text] [Related]
19. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.
Delaleu N; Mydel P; Kwee I; Brun JG; Jonsson MV; Jonsson R
Arthritis Rheumatol; 2015 Apr; 67(4):1084-95. PubMed ID: 25545990
[TBL] [Abstract][Full Text] [Related]
20. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
